Compare EXAS & WSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EXAS | WSO |
|---|---|---|
| Founded | 1995 | 1945 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Industrial Machinery/Components |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.6B | 16.5B |
| IPO Year | N/A | N/A |
| Metric | EXAS | WSO |
|---|---|---|
| Price | $103.38 | $421.23 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 19 | 7 |
| Target Price | $84.27 | ★ $413.33 |
| AVG Volume (30 Days) | ★ 2.4M | 481.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 2.85% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $19.40 | $5.49 |
| Revenue Next Year | $13.54 | $5.79 |
| P/E Ratio | ★ N/A | $34.34 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $38.81 | $323.05 |
| 52 Week High | $103.54 | $535.40 |
| Indicator | EXAS | WSO |
|---|---|---|
| Relative Strength Index (RSI) | 69.20 | 66.95 |
| Support Level | $103.14 | $401.39 |
| Resistance Level | $103.87 | $437.18 |
| Average True Range (ATR) | 0.35 | 14.91 |
| MACD | -0.12 | 0.78 |
| Stochastic Oscillator | 72.08 | 74.22 |
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.
Watsco is the largest heating, ventilation, air conditioning, and refrigeration products distributor in North America. The company primarily operates in the United States (90% of revenue), with significant exposure in the Sun Belt states. Watsco also has operations in Canada (5% of sales) and Latin America (5% of sales). The company's customer base consists of more than 125,000 contractors that serve the replacement and new construction HVACR markets for residential and light commercial applications.